Special Issue “Advances in Antiviral Agents against SARS-CoV-2 and Its Variants”-Reference-Cited by-同舟云学术

Special Issue “Advances in Antiviral Agents against SARS-CoV-2 and Its Variants”

Published:2023-09-10 Issue:9 Volume:15 Page:1905
ISSN:1999-4915
Container-title:Viruses
language:en
Short-container-title:Viruses

Author:

Esposito Francesca¹^ORCID,Cannalire Rolando²

Affiliation:

1. Department of Life and Environmental Sciences, University of Cagliari, Cittadella Universitaria SS554, 09042 Monserrato, Italy

2. Department of Pharmacy, University of Naples Federico II, via D. Montesano 49, 80131 Naples, Italy

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with 770 million reported cases and around 7 million deaths, represents the worst pandemic in the last 100 years [...]

Publisher

MDPI AG

Subject

Virology,Infectious Diseases

Link

https://www.mdpi.com/1999-4915/15/9/1905/pdf

Reference9 articles.

1. Iaconis, D., Caccuri, F., Manelfi, C., Talarico, C., Bugatti, A., Filippini, F., Zani, A., Novelli, R., Kuzikov, M., and Ellinger, B. (2023). DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action. Viruses, 15.

2. Akinosoglou, K., Rigopoulos, E.A., Schinas, G., Kaiafa, G., Polyzou, E., Tsoupra, S., Tzouvelekis, A., Gogos, C., and Savopoulos, C. (2023). Remdesivir Use in the Real-World Setting: An Overview of Available Evidence. Viruses, 15.

3. Gidari, A., Sabbatini, S., Schiaroli, E., Bastianelli, S., Pierucci, S., Busti, C., Saraca, L.M., Capogrossi, L., Pasticci, M.B., and Francisci, D. (2023). Synergistic Activity of Remdesivir–Nirmatrelvir Combination on a SARS-CoV-2 In Vitro Model and a Case Report. Viruses, 15.

4. Cai, J.-P., Luo, C., Wang, K., Cao, H., Chen, L.-L., Zhang, X., Han, Y., Yin, F., Zhang, A.J., and Chu, H. (2023). Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of Mice. Viruses, 15.

5. Hussein, M., dos Ramos, Z.A., Vink, M.A., Kroon, P., Yu, Z., Enjuanes, L., Zúñiga, S., Berkhout, B., and Herrera-Carrillo, E. (2023). Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2. Viruses, 15.